The market for Oxidative Stress Assay is expected to reach US$ XX in 2026.
Oxidative stress is a result of an imbalance between reactive oxygen species and the body's ability to detoxify them. Such discrepancies in the redox state of the cell lead to the generation of peroxides and free radicals that may damage the cell's components, including lipids, proteins, and DNA. The oxidative stress assay measures the level of oxidative stress in cells, which can lead to cancer, Parkinson's and Alzheimer's disease, atherosclerosis, and inflammatory diseases, among other things. The prime factors for the market's growth include technological advancements in oxidative stress assay equipment, prompt growth in pharmaceutical and biotechnology companies, and rising government funding for life science research in developed countries. Additionally, the rise in end-users for oxidative stress assays is expected to catalyze the market's growth. During the forecast period, however, market growth was hampered by the high cost of equipment as well as a lack of public awareness and skilled professionals.
The global oxidative stress assay market is segmented based on test types, technologies, end-users, and geography. Based on the test types, the global market is segmented into assays for antioxidant capacity, indirect assays, reactive oxygen species (ROS)-based assays, and enzyme-based assays. Based on the technologies, the market is segmented into chromatography, enzyme-linked immunosorbent assay (ELISA), microscopy, flow cytometry, label-free detection technology, and high-content screening. In 2017, the ELISA segment dominated the global market owing to the high adoption of the assays and their better specificity and sensitivity. Based on the end-users, the global market is segmented into biotechnology and pharmaceutical companies, clinical laboratories, contract research organizations (CROs), and academic research institutes.
In 2017, North America dominated the global market, followed by Europe. The region's dominance is attributed to technological advancements and the availability of advanced infrastructure. Furthermore, the rising geriatric pool fuels the market. According to the US Census Bureau, the population of the United States above 60 years of age is expected to rise from 10.4 percent in 2015 to 12.5 percent in 2025. The Asia Pacific region is identified as the fastest-growing market due to rising healthcare infrastructure and favorable government initiatives.
Global Oxidative Stress Assay Market, by Test Type, 2016–2026 (US$ Mn)
Global Oxidative Stress Assay Market, by Technology, 2016–2026 (US$ Mn)
Global Oxidative Stress Assay Market, by End-Users, 2016–2026 (US$ Mn)
Global Oxidative Stress Assay Market by Geography (US$ Mn), 2016-2026
Europe
Asia Pacific
Latin America
Middle East and Africa
AMS Biotechnology, Abcam PLC, Merck & Co., Inc., BioVision Inc., Cell Biolabs Inc., Oxford Biomedical Research, Enzo Biochem, Sigma-Aldrich Corporation, QIAGEN N.V., Thermo Fisher Scientific, and Promega Corporation
The market for Oxidative Stress Assay is expected to reach US$ XX in 2026.
The Oxidative Stress Assay market is expected to see significant CAGR growth over the coming years,at XX%.
The report is forecasted from 2018-2026.
The base year of this report is 2017.